GAITHERSBURG, Md. (EGMN) – Food and Drug Administration’s Anti-Infective Drugs Advisory Committee on Sept. 7 voted 18-0 that ceftaroline has been shown to be safe and effective for treating complicated skin and skin structure infections, based on the results of two clinical trials.
